Related Experiment Video
Updated: Apr 28, 2026
08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
829
Ethical issues in the management of thyroid disease
1Program for Bioethics, Department of Internal Medicine, University of Kentucky, 740 S. Limestone Street, Suite K-522, Lexington, KY 40506, USA.
Summary
This article explores clinical ethics in thyroid disease care, covering patient consent, treatment risks, and end-of-life decisions. It addresses ethical challenges in managing autoimmune thyroid conditions and thyroid cancer.
Area of Science:
- Bioethics
- Clinical Ethics
- Endocrinology
Background:
- Clinical ethics addresses bedside dilemmas in the provider-patient relationship.
- Ethical issues in healthcare are diverse, including consent, risk-benefit analysis, and access.
Purpose of the Study:
- To review core ethical principles for clinical practice.
- To discuss moral and legal requirements of informed consent.
- To examine unique and universal ethical issues in thyroid disease management.
Main Methods:
- Literature review of clinical ethics principles.
- Analysis of ethical considerations in thyroid disease (autoimmune and cancer).
Main Results:
- Core ethical principles and informed consent requirements are essential.
- Thyroid disease management presents specific ethical challenges.
Conclusions:
- Understanding clinical ethics is crucial for optimal patient care in endocrinology.
- Ethical frameworks must be applied to autoimmune thyroid disease and thyroid cancer.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
26
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26
01:28Graves' Disease I: Introduction
22
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
22
01:25Hyperthyroidism I: Introduction
29
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
29
01:24Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
01:23Hypothyroidism II: Pathophysiology
23
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
23
01:20Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K